Ibrutinib inhibits BMX-dependent endothelial VCAM-1 expression in vitro and pro-atherosclerotic endothelial activation and platelet adhesion in vivo

© 2022 The Author(s) under exclusive licence to Biomedical Engineering Society.

Detalhes bibliográficos
Autor principal: Kohs, Tia C. L. (author)
Outros Autores: Olson, Sven R. (author), Pang, Jiaqing (author), Jordan, Kelley R. (author), Zheng, Tony J. (author), Xie, Aris (author), Hodovan, James (author), Muller, Matthew (author), McArthur, Carrie (author), Johnson, Jennifer (author), Sousa, Bárbara B. (author), Wallisch, Michael (author), Kievit, Paul (author), Aslan, Joseph E. (author), Seixas, João D. (author), Bernardes, Gonçalo J. L. (author), Hinds, Monica T. (author), Lindner, Jonathan R. (author), McCarty, Owen J. T. (author), Puy, Cristina (author), Shatzel, Joseph J. (author)
Formato: article
Idioma:eng
Publicado em: 2022
Assuntos:
Atherosclerosis
BMX
BTK
Endothelial cell
Ibrutinib
Platelet
TEC
Tyrosine kinase
Texto completo:http://hdl.handle.net/10451/53321
País:Portugal
Oai:oai:repositorio.ul.pt:10451/53321

Texto Completo

http://hdl.handle.net/10451/53321

Registos relacionados